Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| azithromycin,(antibiotic)s[CFS] - Escherichia coli `BL21-Gold(DE3)pLysS AG` |
👶
Changes in the intestinal microbiota following the administration of azithromycin in a randomised placebo-controlled trial among infants in south India Scientific Reports (Sci Rep ) Vol: 7 Issue Pages: 9168 Pub: 2017 Aug 23 Epub: 2017 Aug 23 Authors Parker EP , Praharaj I , John J , Kaliappan SP , Kampmann B , Kang G , Grassly NC , Html Article Publication |
| azithromycin,(antibiotic)s[CFS] - Escherichia coli `BL21-Gold(DE3)pLysS AG` |
👶
Azithromycin resistance in Shiga-toxin Producing Escherichia coli in France between 2004 and 2020 and detection of mef(C)-mph(G) genes. Antimicrobial agents and chemotherapy (Antimicrob Agents Chemother ) Vol: Issue Pages: AAC0194921 Pub: 2021 Dec 6 Epub: 2021 Dec 6 Authors Bizot E , Cointe A , Bidet P , Mariani-Kurkdjian P , Hobson CA , Courroux C , Liguori S , Bridier-Nahmias A , Magnan M , Merimèche M , Caméléna F , Berçot B , Weill FX , Lefèvre S , Bonacorsi S , Birgy A , Publication |
| azithromycin,(antibiotic)s[CFS] - Escherichia coli `BL21-Gold(DE3)pLysS AG` |
👶
Prevalence of genotypic antimicrobial resistance in clinical Shiga toxin-producing Escherichia coli in Norway, 2018 to 2020. Journal of medical microbiology (J Med Microbiol ) Vol: 70 Issue 12 Pages: Pub: 2021 Dec Epub: Authors Ramstad SN , Brandal LT , Taxt AM , Wasteson Y , Bjørnholt JV , Naseer U , Publication |
| azithromycin,(antibiotic)s[CFS] - Escherichia coli `BL21-Gold(DE3)pLysS AG` |
👶
Unravelling the collateral damage of antibiotics on gut bacteria. Nature (Nature ) Vol: 599 Issue 7883 Pages: 120-124 Pub: 2021 Nov Epub: 2021 Oct 13 Authors Maier L , Goemans CV , Wirbel J , Kuhn M , Eberl C , Pruteanu M , Müller P , Garcia-Santamarina S , Cacace E , Zhang B , Gekeler C , Banerjee T , Anderson EE , Milanese A , Löber U , Forslund SK , Patil KR , Zimmermann M , Stecher B , Zeller G , Bork P , Typas A , Publication |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.